Department of Licensing and Regulatory Affairs
Bureau of Professional Licensing
NOTICE OF PUBLIC HEARING
October 4, 2019
9:00 a.m.
Location: G. Mennen Williams Building Auditorium
525 W. Ottawa Street, Lansing, Michigan
The hearing is held to receive public comments on the following administrative rules:
Board of Pharmacy – General Rules (ORR #2018-039 LR)
Authority: MCL 333.16145; MCL 333.16148; MCL 333.16174; MCL 333.16175; MCL
333.16178; MCL 333.16182; MCL 333.16186; MCL 333.17722; MCL 333.17731; MCL
333.17737; MCL 333.17746; MCL 333.17748; MCL 333.17748a; MCL 333.17748b; MCL
333.17751; MCL 333.17753; MCL 333.17757; MCL 333.17760; MCL 333.17767; MCL
338.3501; MCL 445.2001; MCL 445.2011; and MCL 445.2030.
Overview: The current Pharmacy – General Rules will be substantially rewritten and
reorganized to provide for rules that encompass all the necessary requirements for licensing and
regulating the practice for pharmacists, interns, preceptors, pharmacies, manufacturers, and
wholesale distributors. The proposed revisions modify the parts pertaining to general provisions,
pharmacist licenses, pharmacy licenses, manufacturer licenses, wholesale distributor licenses,
and the practice of pharmacy.
Board of Pharmacy – Pharmacist Continuing Education (ORR #2019-022 LR)
Authority: MCL 333.16145; MCL 333.16148; MCL 333.16184; MCL 333.16201; MCL
333.16204; MCL 333.16205; MCL 333.17731; MCL 333.17737; MCL 333.17767; MCL
338.3501; MCL 445.2001; MCL 445.2011; and MCL 445.2030.
Overview: The proposed changes will: require completion of training for identifying victims of
human trafficking and training in opioids and other controlled substances awareness before
renewal of the license; clarify that continuing education (CE) is only required if a licensee has been
licensed for a full 2-year license cycle; require 1 hour of CE in pharmacy ethics and jurisprudence;
clarify the pain and symptom management requirement; limit CE credit for taking the same CE
course or program twice during 1 renewal period; require documentation of meeting CE
requirements; require a waiver request prior to the expiration date of the license; modify CE
approval standards; organize CE activities in a table; add CE activities for credit; require specific
proof for CE; and rescind the CE rule regarding renewal requirements for a pharmacist who
resides or practices in another state.
The rules will take effect immediately upon filing with the Secretary of State, unless specified
otherwise in the rules. Comments on the proposed rules may be presented in person at the public
hearing. Written comments will also be accepted from date of publication until 5:00 p.m. on October
4, 2019, at the following address or e-mail address:
Department of Licensing and Regulatory Affairs
Bureau of Professional Licensing– Boards and Committees Section
